Stock & Company Details
Celularity Inc $CELU
Price:
N/A
N/A
29M
$37M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.35
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CELU technical indicators
Latest Celularity Inc (CELU) indicator readings as of 2026-09-18.
CELU's 14-day RSI is 51.8, in neutral territory. At $1.31 it is trading 16.8% above its 200-day moving average of $1.12, and above its 50-day average of $1.01. Price sits in the middle of its Bollinger Bands ($0.66 to $2.18). ADX reads 39.6, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Finance Bot
Ask your questions
Start by typing a question below.
